Status:
COMPLETED
COVID-19 Infection and Multiple Myeloma
Lead Sponsor:
Stichting European Myeloma Network
Collaborating Sponsors:
Fondazione EMN Italy Onlus
Conditions:
Multiple Myeloma
Covid19
Eligibility:
All Genders
18-99 years
Brief Summary
Collect in an observational study the outcomes of COVID19 infection in MM patients across Europe.
Detailed Description
Coronavirus Disease 2019 (COVID-19), caused by a novel coronavirus (SARS-CoV-2), is a highly contagious disease that appeared in Wuhan, Hubei province of China in December 2019. It has now spread to m...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Multiple Myeloma patients
- COVID-19 infection
Exclusion
Key Trial Info
Start Date :
July 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2024
Estimated Enrollment :
1054 Patients enrolled
Trial Details
Trial ID
NCT04492371
Start Date
July 1 2020
End Date
March 1 2024
Last Update
March 5 2024
Active Locations (8)
Enter a location and click search to find clinical trials sorted by distance.
1
General Hopspital Vienna/Medical University
Vienna, Austria
2
UCL Saint-Luc
Brussels, Belgium
3
University Hospital Ostrava
Ostrava, Czechia
4
University Hospital Würzburg
Würzburg, Germany